Joint Corp. (JYNT)

In August 2025, The Joint Corp. reported a revenue increase of 5% and a 2.6% rise in system-wide sales for Q2 2025. In November 2025, despite beating EPS forecasts, the stock plummeted due to a decrease in system-wide sales. The company is shifting towards becoming a pure-play franchisor through refranchising efforts and clinic closures. Over the past year, the stock has fluctuated between $7.50 and $13.47, with insider buying activity observed.

Demand for The Joint Corp.'s chiropractic services can fluctuate with seasonal transitions. Changes in weather and lifestyle can influence the need for chiropractic care, potentially increasing demand during periods of seasonal transition.

The Joint Corp. is the largest franchisor and operator of chiropractic clinics in the US, providing accessible chiropractic adjustments through a no-appointment, walk-in model. The company operates within the Healthcare Providers industry, specifically under Offices of Chiropractors.

The Joint Corp. is headquartered in Scottsdale, Arizona, and has a nationwide presence with 967 clinics across 43 states as of June 30, 2025. The network includes 885 franchised and 82 corporate clinics, serving over 14 million patient visits annually.

The Joint Corp. maintains a strong brand reputation, consistently recognized on lists such as Franchise Times'

The Joint Corp.'s ownership is primarily held by institutional investors, including Bandera Partners LLC, Vanguard Group Inc, and BlackRock, Inc. Individual insiders, such as Charles Jobson and Christopher Grandpre, also hold significant positions.